These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2127684)

  • 21. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
    Narumi S; Nagawa Y
    Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions.
    Yarbrough GG; Kamath J; Winokur A; Prange AJ
    Med Hypotheses; 2007; 69(6):1249-56. PubMed ID: 17553626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrotropin-releasing hormone (protirelin) inhibits potassium-stimulated glutamate and aspartate release from hippocampal slices in vitro.
    Nie Y; Schoepp DD; Klaunig JE; Yard M; Lahiri DK; Kubek MJ
    Brain Res; 2005 Aug; 1054(1):45-54. PubMed ID: 16055093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome.
    Lechan RM; Fekete C
    J Endocrinol Invest; 2004; 27(6 Suppl):105-19. PubMed ID: 15481810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
    Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
    Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyrotropin-releasing hormone (TRH) modulates vasopressin and oxytocin release from the hypothalamo-neurohypophysial system in dehydrated rats.
    Ciosek J; Guzek JW; Orłowska-Majdak M
    J Physiol Pharmacol; 1993 Sep; 44(3):293-302. PubMed ID: 8241530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin releasing hormone: centrally mediated effects on gastrointestinal motor activity.
    LaHann TR; Horita A
    J Pharmacol Exp Ther; 1982 Jul; 222(1):66-70. PubMed ID: 6806468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of TRH on central nervous system function.
    Breese GR; Mueller RA; Mailman RB; Frye GD
    Prog Clin Biol Res; 1981; 68():99-116. PubMed ID: 6117881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
    Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
    Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of thyrotropin-releasing hormone on phencyclidine- and ketamine-induced spinal depression in neonatal rats.
    Ohno Y; Warnick JE
    Neuropharmacology; 1988 Oct; 27(10):1013-8. PubMed ID: 3148870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between TRH and ethanol in the medial septum.
    McCown TJ; Moray LJ; Kizer JS; Breese GR
    Pharmacol Biochem Behav; 1986 May; 24(5):1269-74. PubMed ID: 3088607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin-releasing hormone (TRH) effects on spinal cord neuronal excitability.
    White SR; Crane GK; Jackson DA
    Ann N Y Acad Sci; 1989; 553():337-50. PubMed ID: 2497678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazole-substituted analogues of TRH limit behavioral deficits after experimental brain trauma.
    Faden AI; Labroo VM; Cohen LA
    J Neurotrauma; 1993; 10(2):101-8. PubMed ID: 8411214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of thyrotropin-releasing hormone and catecholaminergic interactions on CNS ethanol sensitivity.
    French TA; Masserano JM; Weiner N
    Alcohol Clin Exp Res; 1993 Feb; 17(1):99-106. PubMed ID: 8095774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats.
    Kinoshita K; Nagao T; Ono H
    Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on the CNS actions of TRH and its analogs.
    Horita A
    Life Sci; 1998; 62(17-18):1443-8. PubMed ID: 9585116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.